Table 1.
Type 2 diabetes, n = 10 | Healthy control, n = 7 | |
---|---|---|
Age (year) | 61 ± 2; | 62 ± 2 |
Weight (kg) | 85 ± 5 | 78 ± 3 |
BMI (kg m−2) | 28.3 ± 1.2* | 24.5 ± 0.8 |
f-B-glucose (mm) | 7.9 ± 0.9* | 4.7 ± 0.3 |
f-S-Insulin (pm) | 72 ± 17* | 39 ± 5 |
W-B glucose clearance (ml min−1 kg−1) | ||
28 mU min−1 m−2 | 2.5 ± 0.6* | 5.7 ± 0.9 |
480 mU min−1 m−2 | 8.9 ± 0.7* | 14.4 ± 0.7 |
BMI, Body mass index; f-B, fasting blood; f-S, fasting serum; W-B glucose clearance, whole body glucose clearance (i.e. glucose infusion rate (mg min−1 kg−1) during the final 30 min of 2-h sequential insulin infusions divided by the prevailing plasma glucose concentration (mg (100 ml)−1)).
Significantly different from control subjects (P < 0.05). Data are mean ± s.e.m.